The FirstTake Podcast – FirstWord’s editors discuss the controversial approval of Biogen’s Aduhelm
FirstTake on Pharma - Pharma News and Analysis Podcast
English - June 10, 2021 21:00 - 30 minutes - 18.4 MB - ★★★★★ - 2 ratingsScience pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The FirstTake Podcast – KRAS, OX40, EQRx and ASCO in focus
FirstWord Pharma PLUS editors Becky Simon, Michael Flanagan and Simon King discuss FDA approval of the first potentially disease modifying Alzheimer’s disease treatment Aduhelm (aducanumab), which has dominated industry headlines this week.
Simon also speaks to EQRx President and Chief Operating Office Melanie Nallicheri about the company’s aspirations to disrupt pharmaceutical pricing and what describes as its “data coming out part” at ASCO this past weekend.